Evidence-Based Decision Making: When Should We Wait For More Information?-Reference-Cited by-同舟云学术

Evidence-Based Decision Making: When Should We Wait For More Information?

Published:2008-11 Issue:6 Volume:27 Page:1642-1653
ISSN:0278-2715
Container-title:Health Affairs
language:en
Short-container-title:Health Affairs

Author:

Chalkidou Kalipso,Lord Joanne,Fischer Alastair,Littlejohns Peter¹

Affiliation:

1. Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland.

Publisher

Health Affairs (Project Hope)

Subject

Health Policy

Reference23 articles.

1. Evidence-Based Coverage Policy

2. Impact Of State Tort Reforms On Physician Malpractice Payments

3. NICE’s approval of Herceptin for use in women with advanced breast cancer triggered the first ever appeal against a positive decision by a public local payer. M.L. Harding, “Drug Funding: Hewitt, Herceptin, and the 100m Pound Sterling Bill PCTs Can’t Afford to Pay,” Health Service Journal 115 , no. 5985 ( 2005 ): 12 –13.

4. Paying For Hospitals’ Community Service

5. Effectiveness and efficiency of guideline dissemination and implementation strategies

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards Sustainable Management of Parkinson’s Disease Healthcare: Evaluating the Role and Impact of Mobile Health Devices (Preprint);2024-06-13

2. Strategic flexibility in healthcare: an exploration of real options;Journal of Economic Studies;2024-02-13

3. Exploring the misalignment on the value of further research between payers and manufacturers. A case study on a novel total artificial heart;Health Economics;2022-04-23

4. Implementation Barriers to Value of Information Analysis in Health Technology Decision Making: Results From a Process Evaluation;Value in Health;2021-08

5. State of the ART? Two New Tools for Risk Communication in Health Technology Assessments;PharmacoEconomics;2021-07-19